AbC-19™ Rapid Test
The AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great results
Diagnostics
It's quite simple and more effective than any other rapid test. However, it is also time consuming.
Review Date: 22 May 2022 | Abingdon Health
The AbC-19™ Rapid Test is able to confirm that IgG antibodies to the full Spike protein have been produced after vaccination or following direct exposure to the SARS-CoV-2 virus.
The AbC-19™ Rapid Test can be deployed across multiple populations and has the potential to inform vaccination programmes and health policy. The test can do this by showing how COVID-19 infection spreads through communities, where any why immunity to COVID-19 might be developing and how mass-immunisation campaigns could be designed.
The AbC-19™ Rapid Test is delivered at point of care (POC) using a blood sample from a finger-stick puncture, with test results ready in just 20 minutes.
Why use the AbC-19™ Rapid Test?
Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
Sensitivity: 98.03%, Specificity: 99.56%*
Minimal operator training required
CE marked for use by healthcare professionals
For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries
